Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.023x

Based on the latest financial reports, Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-17.57 Million ≈ $-2.57 Million USD) by net assets (CN¥756.82 Million ≈ $110.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300534 stock market capitalisation for the company's overall valuation and market capitalisation.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency. Explore Gansu Longshenrongfa Pharmaceutical Indu cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jiangsu Yueda Investment Co Ltd SHG:600805	0.002x
Akva Group OL:AKVA	0.066x
Zhejiang Yatai Pharmaceutical Co Ltd SHE:002370	-0.006x
Trilogy Metals Inc TO:TMQ	-0.023x
Haesung DS Co Ltd KO:195870	0.049x
Shanghai Sheng Jian Environment Technology Co Ltd SHG:603324	-0.008x
Shanghai Amarsoft Information & Technolgy Co Ltd SHE:300380	-0.053x
Hangzhou Anysoft Information Technology Co Ltd SHE:300571	0.066x

Annual Cash Flow Conversion Efficiency for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025. View Gansu Longshenrongfa Pharmaceutical Indu (300534) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥781.08 Million ≈ $114.30 Million	CN¥-6.54 Million ≈ $-956.57K	-0.008x	-103.58%
2024-12-31	CN¥727.93 Million ≈ $106.52 Million	CN¥170.14 Million ≈ $24.90 Million	0.234x	+72.29%
2023-12-31	CN¥711.51 Million ≈ $104.12 Million	CN¥96.53 Million ≈ $14.12 Million	0.136x	+806.01%
2022-12-31	CN¥763.13 Million ≈ $111.67 Million	CN¥11.43 Million ≈ $1.67 Million	0.015x	-78.54%
2021-12-31	CN¥732.84 Million ≈ $107.24 Million	CN¥51.13 Million ≈ $7.48 Million	0.070x	+18.56%
2020-12-31	CN¥739.13 Million ≈ $108.16 Million	CN¥43.50 Million ≈ $6.37 Million	0.059x	+54.16%
2019-12-31	CN¥738.88 Million ≈ $108.12 Million	CN¥28.21 Million ≈ $4.13 Million	0.038x	+168.93%
2018-12-31	CN¥720.83 Million ≈ $105.48 Million	CN¥10.23 Million ≈ $1.50 Million	0.014x	+592.28%
2017-12-31	CN¥712.19 Million ≈ $104.22 Million	CN¥-2.05 Million ≈ $-300.53K	-0.003x	-115.45%
2016-12-31	CN¥703.74 Million ≈ $102.98 Million	CN¥13.14 Million ≈ $1.92 Million	0.019x	-75.26%
2015-12-31	CN¥405.57 Million ≈ $59.35 Million	CN¥30.60 Million ≈ $4.48 Million	0.075x	-29.77%
2014-12-31	CN¥363.10 Million ≈ $53.13 Million	CN¥39.01 Million ≈ $5.71 Million	0.107x	-4.61%
2013-12-31	CN¥318.92 Million ≈ $46.67 Million	CN¥35.92 Million ≈ $5.26 Million	0.113x	-45.79%
2012-12-31	CN¥171.46 Million ≈ $25.09 Million	CN¥35.62 Million ≈ $5.21 Million	0.208x	-7.30%
2011-12-31	CN¥45.35 Million ≈ $6.64 Million	CN¥10.16 Million ≈ $1.49 Million	0.224x	--

About Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

SHE:300534 China Drug Manufacturers - Specialty & Generic

Market Cap

$555.31 Million

CN¥3.79 Billion CNY

Market Cap Rank

#11725 Global

#3322 in China

Share Price

CN¥12.51

Change (1 day)

-2.04%

52-Week Range

CN¥6.95 - CN¥20.23

All Time High

CN¥29.78